SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025 |
Jun. 30, 2026
USD ($)
company
segment
|
Jun. 30, 2025
company
|
Jun. 30, 2026
USD ($)
company
|
Dec. 31, 2025
USD ($)
|
|||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Cash equivalents | $ 3,800 | $ 3,800 | $ 3,800 | $ 3,200 | ||||||||||||||||||||||
| Cash exceeded federal deposit insurance corporation insurance protection levels | 51,900 | 51,900 | 51,900 | 35,400 | ||||||||||||||||||||||
| Fair value | 5,746,044 | [1],[2],[3] | 5,746,044 | [1],[2],[3] | 5,746,044 | [1],[2],[3] | 5,518,117 | [4],[5],[6] | ||||||||||||||||||
| Cost | $ 4,974,649 | [1],[3],[7] | $ 4,974,649 | [1],[3],[7] | 4,974,649 | [1],[3],[7] | 4,724,528 | [4],[6],[8] | ||||||||||||||||||
| Percentage of total investment income, attributable to noncash paid-in-kind interest income (as a percent) | 2.90% | 2.30% | 2.80% | 2.60% | ||||||||||||||||||||||
| Percentage of total investment come, attributable to noncash cumulative dividend income (as a percent) | 0.70% | 0.90% | 0.70% | 0.70% | ||||||||||||||||||||||
| Percentage of total investment income, attributable to interest income, debt investments, net (as a percent) | 1.60% | 1.70% | 1.60% | 1.70% | ||||||||||||||||||||||
| Number of operating segments | segment | 1 | |||||||||||||||||||||||||
| Number of reportable segments | segment | 1 | |||||||||||||||||||||||||
| Revolving Credit Facility | Line of Credit | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Commitment fee (as a percentage) | 3.40% | |||||||||||||||||||||||||
| Non-accrual Status | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Fair value | $ 65,200 | $ 65,200 | 65,200 | 56,300 | ||||||||||||||||||||||
| Cost | 198,500 | $ 198,500 | $ 198,500 | $ 155,300 | ||||||||||||||||||||||
| Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Concentration risk (as a percent) | 100.00% | 100.00% | ||||||||||||||||||||||||
| Investment Owned, At Fair Value | Investment Type Concentration Risk | Non-accrual Status | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Concentration risk (as a percent) | 1.10% | 1.00% | ||||||||||||||||||||||||
| Investment Owned, At Cost | Investment Type Concentration Risk | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Concentration risk (as a percent) | 100.00% | 100.00% | ||||||||||||||||||||||||
| Investment Owned, At Cost | Investment Type Concentration Risk | Non-accrual Status | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Concentration risk (as a percent) | 4.00% | 3.30% | ||||||||||||||||||||||||
| LMM portfolio investments | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Consultation period subsequent to initial investment (in months) | 12 months | |||||||||||||||||||||||||
| Investment company, number of portfolio companies with annual third-party appraisal was obtained, reviewed and certified | company | 19 | 19 | 73 | |||||||||||||||||||||||
| Percentage of portfolio with annual third-party appraisal was obtained, reviewed and certified (as a percent) | 96.00% | |||||||||||||||||||||||||
| Fair value | 3,205,600 | $ 3,205,600 | $ 3,205,600 | $ 3,057,000 | ||||||||||||||||||||||
| Cost | 2,547,700 | $ 2,547,700 | $ 2,547,700 | 2,419,300 | ||||||||||||||||||||||
| LMM portfolio investments | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Concentration risk (as a percent) | 21.00% | 23.00% | 92.00% | |||||||||||||||||||||||
| Private Loan portfolio investments | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Consultation period subsequent to initial investment (in months) | 12 months | |||||||||||||||||||||||||
| Investment company, number of portfolio companies with annual third-party appraisal was obtained, reviewed and certified | company | 18 | 19 | 65 | |||||||||||||||||||||||
| Percentage of portfolio with annual third-party appraisal was obtained, reviewed and certified (as a percent) | 98.00% | |||||||||||||||||||||||||
| Fair value | 2,090,900 | $ 2,090,900 | $ 2,090,900 | 1,988,400 | ||||||||||||||||||||||
| Cost | $ 2,123,500 | $ 2,123,500 | $ 2,123,500 | $ 2,014,100 | ||||||||||||||||||||||
| Private Loan portfolio investments | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Concentration risk (as a percent) | 26.00% | 26.00% | 92.00% | |||||||||||||||||||||||
| Middle Market portfolio investments | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Percentage of portfolio investments containing limited consultation with financial advisory services firm (as a percent) | 92.00% | 92.00% | 92.00% | 95.00% | ||||||||||||||||||||||
| Fair value | $ 83,100 | $ 83,100 | $ 83,100 | $ 83,500 | ||||||||||||||||||||||
| Cost | 123,100 | $ 123,100 | 123,100 | $ 120,100 | ||||||||||||||||||||||
| Middle Market portfolio investments | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Concentration risk (as a percent) | 1.40% | 1.50% | ||||||||||||||||||||||||
| Middle Market portfolio investments | Investment Owned, At Cost | Investment Type Concentration Risk | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Concentration risk (as a percent) | 2.50% | 2.50% | ||||||||||||||||||||||||
| Other Portfolio investments | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Fair value | 141,300 | $ 141,300 | 141,300 | $ 134,100 | ||||||||||||||||||||||
| Cost | $ 150,800 | $ 150,800 | $ 150,800 | $ 141,600 | ||||||||||||||||||||||
| Other Portfolio investments | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Concentration risk (as a percent) | 2.50% | 2.40% | ||||||||||||||||||||||||
| Other Portfolio investments | Investment Owned, At Cost | Investment Type Concentration Risk | ||||||||||||||||||||||||||
| Schedule of Investments [Line Items] | ||||||||||||||||||||||||||
| Concentration risk (as a percent) | 3.00% | 3.00% | ||||||||||||||||||||||||
| ||||||||||||||||||||||||||